Burn-specific sepsis definitions and diagnostic biomarkers

Overview¶

Sepsis is the dominant lethal complication of burn injury. Across decades of single-center and registry data it is reported as the leading cause of death in burn patients ^[12], and remains the primary cause of death for those who survive their acute injury and resuscitation ^[11]. One adult series attributed over 50% of mortality to sepsis ^[13], and sepsis episodes characteristically emerge after the resuscitation window, with a median time to first episode of 7 days and an average of roughly 13 days spent in sepsis ^[14].

The clinical problem is not that sepsis is rare but that it is hard to name. The hypermetabolic, hyperinflammatory physiology of a major burn reproduces the same vital-sign and laboratory derangements that define sepsis in other populations, so the diagnostic signal a clinician relies on elsewhere is buried in burn-injury noise ^[33]. That tension, a high-stakes and high-frequency complication with no reliable definition at the point of care, is what this topic addresses, and it is the reason a dedicated burn-specific definition and a dedicated biomarker literature exist.

The definitional problem¶

Standard sepsis definitions break down in burns at their root. By definition, a patient with an extensive burn already meets systemic inflammatory response syndrome criteria from the burn itself ^[1]. The early sepsis frameworks, the 1992 American College of Chest Physicians and Society of Critical Care Medicine definition and its SIRS-based successors, therefore lose discriminating power ^{[1] [43]}. In a validation cohort, SIRS criteria were met by 98% of burn subjects, leaving them effectively non-discriminative ^[9]. More broadly, the criteria that define sepsis elsewhere (fever, tachycardia, tachypnea, leukocytosis) are routinely present in extensive burns, which is the stated reason the original ABA consensus judged standard definitions less applicable to this population ^[1].

A second structural problem compounds the first: burns have historically been excluded from the large studies that built modern sepsis definitions and therapy ^[33]. The Sepsis-3 framework (SOFA and qSOFA) was derived in general critically ill populations, not in burn patients ^[27], and burn patients were excluded from essentially every sepsis trial underpinning current practice ^[29]. The result is a definition vacuum that the burn community has had to fill on its own.

Classification¶

The central definitional landmark is the 2007 American Burn Association consensus conference. Its stated goal was to develop and publish standardized definitions for sepsis and infection-related diagnoses specific to the burn population ^[1], because standardized definitions for infection and sepsis in burn patients had never been formally developed and the general definitions fit poorly ^[18]. A parallel Chinese consensus from the same year similarly recommended treating suspected systemic infection as a clinical syndrome defined by signs and symptoms even with negative blood cultures, and expanded the diagnostic-criteria list to reflect burn clinical experience ^[18].

The ABA 2007 criteria are a trigger-based construct. They include a temperature above 39°C or below 36°C, progressive tachycardia above 110 beats per minute, progressive tachypnea, and thrombocytopenia below 100,000/μL not applied until three days after resuscitation ^[2]. Meeting more than three of these should "trigger" concern for infection rather than confirm it ^[2]. The framing is deliberate: the criteria were built as a sensitive alarm to prompt a diagnostic search, not as a confirmatory standard.

Assessment¶

In practice, assessment in burn sepsis is multi-modal, reading clinical trajectory, microbiology, and biomarker trend together, because no element is sufficient alone. The ABA trigger has repeatedly underperformed as a stand-alone test: in a retrospective chart review the ABA trigger did not correlate strongly with bacteremia ^[2], and its predictive usefulness was limited to the single day before a positive blood culture was obtained ^[9]. The criteria have demonstrated poor specificity for identifying sepsis and septic shock ^[3], consistent with the broader finding that traditional sepsis indicators perform poorly in the hypermetabolic burn population ^[32].

Newer derived models have tried to do better. A data-driven model built from burn-center physiology, including temperature above 39°C or below 36°C, heart rate above 130, a 10% fall in mean arterial pressure, and elevated gastric residual volumes, identified sepsis with positive bloodstream infection and outperformed existing models in its derivation cohort, with meeting at least one variable being the best-performing threshold ^[19]. The Mann-Salinas predictors were similarly reported to outperform the ABA criteria ^[9], and an automated algorithmic case-finding method incorporating ABA sepsis criteria achieved an accuracy of 86.0% for identifying burn sepsis ^[28].

Direct head-to-head comparisons of definition systems are mixed. One validation study found Sepsis-3 the most predictive, followed by the ABA and Mann-Salinas criteria, but concluded that no criterion alone had the accuracy to serve as a diagnostic standard in burns ^[10]. Another found both the older SIRS-based (Sepsis-1) and the Sepsis-3 guidelines inappropriate for diagnosing sepsis in severe burns ^[21]. Organ-dysfunction scoring may carry more weight than vital-sign triggers: a large comparison reported that a Sequential Organ Failure Assessment score of at least 6 (with infection) achieved an accuracy of 0.86 and may be a better diagnostic criterion than the trigger-based definitions, even though the Sepsis-3 criteria did not show superior mortality-prognostic accuracy overall ^[7]. A 2026 temporal-validation study reinforced the organ-dysfunction emphasis, finding creatinine elevation and thrombocytopenia to be the key subsystem-specific SOFA indicators in burn sepsis ^[31].

Management¶

Once sepsis is suspected, the diagnostic question becomes which biomarker, if any, adds confidence beyond the clinical and microbiologic picture. The literature is heterogeneous, and the most robust message is a negative one: no biomarker functions as a stand-alone standard, and conventional inflammatory markers are frequently elevated by the burn itself, limiting their specificity ^[41].

Procalcitonin (PCT) is the most-studied marker. High serum PCT concentrations occur with bacterial infection and sepsis ^[5], and an early burn study found septic patients had higher plasma PCT throughout the study period while CRP differences were less pronounced and never reached significance ^[5]; the authors concluded PCT was a highly efficient parameter for diagnosing severe infectious complications after burn injury ^[5]. Later work is more guarded. In an ICU burn cohort, PCT did not appear superior to CRP and white blood cell count as a diagnostic marker ^[15], and another study found PCT was not a precise indicator of sepsis at the time of diagnosis, correlating instead with hypoperfusion ^[16]. A 2026 temporal study found PCT's diagnostic utility confined to the late phase of the burn course ^[31].

Trend and kinetics often outperform single values. A statistically significant rise in mean PCT accompanied the sepsis period in critically ill septic burn patients ^[4], and in a presepsin study septic time points differed significantly from non-sepsis points in presepsin, PCT, and CRP, while on the first day of sepsis presepsin, CRP, and WBC, but not PCT, differed significantly from prior days ^[22]. This day-over-day-divergence pattern is why serial measurement is emphasized over isolated cutoffs.

Other markers. Presepsin (soluble CD14 subtype) performed comparably to PCT, with diagnostic AUC-ROC values of 83.4% for presepsin, 84.7% for PCT, 81.9% for CRP, and 50.8% for WBC in one burn-sepsis cohort ^[22]. Neutrophil CD64 (nCD64) showed good diagnostic value with a pooled sensitivity of 0.92 and specificity of 0.82 in a Chinese burn population ^[23]. Natriuretic peptides have been studied for prognosis rather than diagnosis: NT-proBNP was an independent risk factor for mortality and proposed as a prognostic marker ^[35], and BNP outperformed PCT and CRP for predicting burn-sepsis prognosis in one series ^[25]. These remain single-center signals rather than established practice.

The 2023 International Society for Burn Injuries Surviving Sepsis After Burn Campaign (SSABC) reframed management at the guideline level. Because sepsis is the primary cause of death after thermal injury yet burns were excluded from prior Surviving Sepsis efforts ^[8], an international group of burn experts developed the SSABC as a testable guideline, producing sixty statements across fourteen topics for the early treatment of burn sepsis ^[8]. It is the first international guideline for managing sepsis in burn patients, and it emphasizes an organ-function-oriented dynamic assessment framework over reliance on traditional biomarkers ^[40].

Special Considerations¶

Pediatric burn sepsis carries its own definition and biomarker literature. Children are at significantly increased risk for infection and sepsis from skin-barrier loss and subsequent immunosuppression ^[34], sepsis is common in pediatric burns and markedly increases morbidity and mortality ^[37], and it carries significantly higher mortality than in adults ^[38]. The pediatric biomarker picture is, if anything, weaker than the adult one: in one pediatric cohort neither CRP nor PCT showed adequate operative capability to detect infection or a fatal outcome ^[17]. A 2025 study reported a 30% prevalence of sepsis among burn-injured children and identified persistent inflammation, immunosuppression, and catabolism syndrome, with lymphopenia as the strongest associated criterion, as independently associated with subsequent sepsis ^[20]. Dedicated pediatric nosocomial-infection definitions were proposed precisely because widely accepted definitions for this population were unavailable ^[44]. PCT also has a population-specific role in inhalation injury, where serum levels were proposed as a prognostic index of severity ^[39].

Outcomes¶

The prognostic stakes of getting the diagnosis right are high. Sepsis is reported as the leading cause of mortality in burn injury and is repeatedly described as a real diagnostic challenge in the same breath ^{[14] [13]}. In one Brazilian case series, sepsis-related death occurred in 50% of affected patients, with a median TBSA of 50% ^[14]. NT-proBNP, BNP, and other markers have been advanced specifically as prognostic rather than diagnostic tools, reflecting the recurring finding that outcome stratification is sometimes more tractable than the diagnosis itself ^{[35] [25]}.

Controversies and Evidence Gaps¶

The unsettled questions in this topic are foundational, not peripheral.

• No consensus standard. Multiple validation studies converge on the conclusion that no single criterion set is accurate enough to be a diagnostic standard in burns ^[10], and that standard diagnostic criteria and biomarkers each fall short of reliable discrimination ^{[16] [41]}.
• Sepsis-3 versus burn-specific criteria is genuinely contested. Some authors argue Sepsis-3 is the best available definition for burn patients despite its non-burn derivation ^[36], and one analysis found it reflects severity without delaying diagnosis ^[24]; others found Sepsis-3 inappropriate for severe burns ^[21], and one report noted SIRS retained higher sensitivity than qSOFA ^[24]. The evidence does not yet adjudicate this cleanly.
• Biomarker cutoffs are not standardized. The most widely studied biomarkers are described as poorly predictive for sepsis in burns ^[6], conventional markers are confounded by burn-driven inflammation ^[41], and markers of the post-burn inflammatory response frequently fail to predict sepsis because they do not track infection severity ^[26].
• Differentiating inflammation from infection drives therapy. Distinguishing sterile burn inflammation from true sepsis is clinically consequential because treatment differs between the two ^[42], yet the masking effect of the hypermetabolic state makes that distinction unreliable in routine clinical assessment ^[33].
• Cross-study comparability is limited. Great variability in the criteria used to identify septic patients compromises comparison across studies ^[27], an issue flagged as early as 1986 with a call for an international standardization register ^[30].
• ABA 2007 validation is mixed. The 2007 criteria are simultaneously the field's anchor and a recurrent target of critique for poor specificity ^{[3] [9]}, leaving the burn community reliant on a definition it has not been able to confirm as accurate.

References¶

[1] Greenhalgh DG, et al. "American Burn Association consensus conference to define sepsis and infection in burns." Journal of burn care & research : official publication of the American Burn Association 2007. PMID: 17925660 ↩

[2] Hogan BK, et al. "Correlation of American Burn Association sepsis criteria with the presence of bacteremia in burned patients admitted to the intensive care unit." Journal of burn care & research : official publication of the American Burn Association 2012. PMID: 22210056 ↩

[3] Ladhani HA, Yowler CJ, Claridge JA. "Burn Wound Colonization, Infection, and Sepsis." Surgical infections 2021. PMID: 33085576 ↩

[4] Lavrentieva A, Kontakiotis T, Bitzani M. "Enteral nutrition intolerance in critically ill septic burn patients." Journal of burn care & research : official publication of the American Burn Association 2014. PMID: 24879397 ↩

[5] Sachse C, Machens HG, Felmerer G, Berger A, Henkel E. "Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury." The Journal of burn care & rehabilitation 1999. PMID: 10501320 ↩

[6] Li AT, et al. "Biomarkers for the Early Diagnosis of Sepsis in Burns: Systematic Review and Meta-analysis." Annals of surgery 2022. PMID: 35261389 ↩

[7] Yoon J, et al. "Comparative Usefulness of Sepsis-3, Burn Sepsis, and Conventional Sepsis Criteria in Patients With Major Burns." Critical care medicine 2018. PMID: 29620554 ↩

[8] Greenhalgh DG, et al. "Surviving Sepsis After Burn Campaign." Burns : journal of the International Society for Burn Injuries 2023. PMID: 37839919 ↩

[9] Mann-Salinas EA, et al. "Novel predictors of sepsis outperform the American Burn Association sepsis criteria in the burn intensive care unit patient." Journal of burn care & research : official publication of the American Burn Association 2013. PMID: 23135212 ↩

[10] Yan J, Hill WF, Rehou S, Pinto R, Shahrokhi S, Jeschke MG. "Sepsis criteria versus clinical diagnosis of sepsis in burn patients: A validation of current sepsis scores." Surgery 2018. PMID: 30049483 ↩

[11] Tejiram S, Shupp JW. "Sepsis in surgical patients: Burn sepsis." Surgery 2024. PMID: 38154995 ↩

[12] Manning J. "Sepsis in the Burn Patient." Critical care nursing clinics of North America 2018. PMID: 30098746 ↩

[13] Pikkel YY, Levy YA, Ramon Y, Tobias T, Zeltzer AA. "Who By Fire? Sepsis in the Adult Burn Patient: Prognostic Factors." The Israel Medical Association journal : IMAJ 2025. PMID: 40819198 ↩

[14] Neiverth A, Prim LR, Franck CL, Nisihara R. "Sepsis in Burned Adult Patients: Study of Serie of Cases in Brazil." Journal of burn care & research : official publication of the American Burn Association 2020. PMID: 32112087 ↩

[15] Bargues L, Chancerelle Y, Catineau J, Jault P, Carsin H. "Evaluation of serum procalcitonin concentration in the ICU following severe burn." Burns : journal of the International Society for Burn Injuries 2007. PMID: 17532575 ↩

[16] Seoane L, Pértega S, Galeiras R, Astola I, Bouza T. "Procalcitonin in the burn unit and the diagnosis of infection." Burns : journal of the International Society for Burn Injuries 2014. PMID: 24439927 ↩

[17] Rosanova MT, et al. "Assessment of C-reactive protein and procalcitonin levels to predict infection and mortality in burn children." Archivos argentinos de pediatria 2015. PMID: 25622159 ↩

[18] Peng YZ, Yuan ZQ. "[Standardized definitions and diagnostic criteria for infection in burn patients]." Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 2007. PMID: 18457247 ↩

[19] Hill DM, et al. "Predictors for Identifying Burn Sepsis and Performance vs Existing Criteria." Journal of burn care & research : official publication of the American Burn Association 2018. PMID: 29771353 ↩

[20] Santarelli MD, et al. "Persistent inflammation, immunosuppression, and catabolism syndrome and sepsis in pediatric burns." Burns : journal of the International Society for Burn Injuries 2025. PMID: 40555121 ↩

[21] Dastagir K, et al. "Application of Critical Care Scores in Severely Burned Patients." Journal of burn care & research : official publication of the American Burn Association 2021. PMID: 33539518 ↩

[22] Cakır Madenci Ö, Yakupoğlu S, Benzonana N, Yücel N, Akbaba D, Orçun Kaptanağası A. "Evaluation of soluble CD14 subtype (presepsin) in burn sepsis." Burns : journal of the International Society for Burn Injuries 2014. PMID: 24074718 ↩

[23] Chen Z, Nurlan T, Ning F, Zha T, Liu X. "Diagnostic Value of Neutrophil CD64 in Burn Patients With Infection in Chinese Population: A Systematic Review and Meta-analysis." Journal of burn care & research : official publication of the American Burn Association 2021. PMID: 33625516 ↩

[24] Yoon J, Kym D, Hur J, Cho YS, Chun W, Yoon D. "Validation of Sepsis-3 using survival analysis and clinical evaluation of quick SOFA, SIRS, and burn-specific SIRS for sepsis in burn patients with suspected infection." PloS one 2023. PMID: 36595535 ↩

[25] Zu H, Li Q, Huang P, Wang X. "Therapeutic Value of Blood Purification and Prognostic Utilities of Early Serum Procalcitonin, C Reactive Protein, and Brain Natriuretic Peptide Levels in Severely Burned Patients with Sepsis." Cell biochemistry and biophysics 2015. PMID: 25561281 ↩

[26] Muñoz B, Suárez-Sánchez R, Hernández-Hernández O, Franco-Cendejas R, Cortés H, Magaña JJ. "From traditional biochemical signals to molecular markers for detection of sepsis after burn injuries." Burns : journal of the International Society for Burn Injuries 2019. PMID: 29802006 ↩

[27] Mann EA, Baun MM, Meininger JC, Wade CE. "Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature." Shock (Augusta, Ga.) 2012. PMID: 21941222 ↩

[28] Rech MA, Mosier MJ, Zelisko S, Netzer G, Kovacs EJ, Afshar M. "Comparison of Automated Methods Versus the American Burn Association Sepsis Definition to Identify Sepsis and Sepsis With Organ Dysfunction/Septic Shock in Burn-Injured Adults." Journal of burn care & research : official publication of the American Burn Association 2017. PMID: 28230556 ↩

[29] Boehm D, Menke H. "Sepsis in Burns-Lessons Learnt from Developments in the Management of Septic Shock." Medicina (Kaunas, Lithuania) 2021. PMID: 35056334 ↩

[30] Bauer M, Stuffer M, Balogh D. "[An analysis of clinical aspects and autopsy protocols of 52 deceased patients with burn injuries]." Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V... 1986. PMID: 3804053 ↩

[31] Su H, Yuan B, Liu Y, Xi W, Qiao L. "Discriminative power of organ-specific SOFA assessment in burn sepsis: A temporal biomarker analysis." Burns : journal of the International Society for Burn Injuries 2026. PMID: 41297233 ↩

[32] Tran NK, et al. "Novel application of an automated-machine learning development tool for predicting burn sepsis: proof of concept." Scientific reports 2020. PMID: 32704168 ↩

[33] Torres MJM, Peterson JM, Wolf SE. "Detection of Infection and Sepsis in Burns." Surgical infections 2021. PMID: 33021433 ↩

[34] Williams FN, Lee JO. "Pediatric Burn Infection." Surgical infections 2021. PMID: 32790497 ↩

[35] Wang Y, Shu Z, Zhu W, Zhou L, Song H, Luo G. "The Prognostic Value of N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) in Major Burn Patients With Sepsis." Journal of burn care & research : official publication of the American Burn Association 2022. PMID: 35303085 ↩

[36] Meza-Escobar LE, Rehou S, Jeschke MG. "Sepsis Definitions in Burns." Surgical infections 2021. PMID: 33026946 ↩

[37] Sheridan RL. "Sepsis in pediatric burn patients." Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2005. PMID: 15857543 ↩

[38] Peng YZ. "[Clinical characteristics and diagnosis of sepsis in pediatric burn patients]." Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 2013. PMID: 23710714 ↩

[39] Nylen ES, et al. "Serum procalcitonin as an index of inhalation injury in burns." Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 1992. PMID: 1427616 ↩

[40] Zhu W, Peng YZ, Luo GX, Yuan ZQ. "[Interpretation of the 2023 International Society for Burn Injuries 'Surviving Sepsis After Burn Campaign']." Zhonghua shao shang yu chuang mian xiu fu za zhi 2025. PMID: 40850826 ↩

[41] Bakalář B, et al. "Validation of the intensive care infection score for infection discrimination in burn patients compared with other inflammatory biomarkers (ICARUS study)." Burns : journal of the International Society for Burn Injuries 2026. PMID: 42119490 ↩

[42] Hidalgo F, Mas D, Rubio M, Garcia-Hierro P. "Infections in critically ill burn patients." Medicina intensiva 2016. PMID: 27013315 ↩

[43] Zhang Q, Liao Z. "[An inquiry into the relevant issues about burn sepsis]." Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 2014. PMID: 24684982 ↩

[44] Weber JM, Sheridan RL, Pasternack MS, Tompkins RG. "Nosocomial infections in pediatric patients with burns." American journal of infection control 1997. PMID: 9202814 ↩